UK markets close in 2 hours 40 minutes

The Chemours Company (CC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
27.91+0.61 (+2.23%)
At close: 04:01PM EDT
28.00 +0.09 (+0.32%)
Pre-market: 04:23AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
6,933,000
6,345,000
4,969,000
5,526,000
6,638,000
Cost of revenue
5,131,000
4,964,000
3,902,000
4,463,000
4,667,000
Gross profit
1,802,000
1,381,000
1,067,000
1,063,000
1,971,000
Operating expenses
Research development
111,000
107,000
93,000
80,000
82,000
Selling general and administrative
677,000
592,000
527,000
548,000
657,000
Total operating expenses
795,000
707,000
620,000
651,000
739,000
Operating income or loss
1,007,000
674,000
447,000
412,000
1,232,000
Interest expense
170,000
185,000
210,000
208,000
195,000
Total other income/expenses net
205,000
187,000
-58,000
-328,000
118,000
Income before tax
1,042,000
676,000
179,000
-124,000
1,155,000
Income tax expense
161,000
68,000
-40,000
-72,000
159,000
Income from continuing operations
881,000
608,000
219,000
-52,000
996,000
Net income
881,000
608,000
219,000
-52,000
995,000
Net income available to common shareholders
881,000
608,000
219,000
-52,000
995,000
Basic EPS
-
3.69
1.33
-0.32
5.62
Diluted EPS
-
3.60
1.32
-0.32
5.45
Basic average shares
-
164,944
164,682
164,817
176,969
Diluted average shares
-
168,698
166,347
167,245
182,572
EBITDA
-
1,178,000
709,000
395,000
1,634,000